These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 35265201)

  • 1. Advances in aptamers against Aβ and applications in Aβ detection and regulation for Alzheimer's disease.
    Zheng Y; Zhang L; Zhao J; Li L; Wang M; Gao P; Wang Q; Zhang X; Wang W
    Theranostics; 2022; 12(5):2095-2114. PubMed ID: 35265201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology.
    Tannenberg RK; Shamaileh HA; Lauridsen LH; Kanwar JR; Dodd PR; Veedu RN
    Curr Alzheimer Res; 2013 May; 10(4):442-8. PubMed ID: 23270374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosensors for Alzheimer's disease biomarker detection: A review.
    Shui B; Tao D; Florea A; Cheng J; Zhao Q; Gu Y; Li W; Jaffrezic-Renault N; Mei Y; Guo Z
    Biochimie; 2018 Apr; 147():13-24. PubMed ID: 29307704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease.
    Rahimi F; Bitan G
    J Vis Exp; 2010 May; (39):. PubMed ID: 20616783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design principles and fundamental understanding of biosensors for amyloid-β detection.
    Zhang Y; Ren B; Zhang D; Liu Y; Zhang M; Zhao C; Zheng J
    J Mater Chem B; 2020 Jul; 8(29):6179-6196. PubMed ID: 32355946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.
    Zhang X; Liu S; Song X; Wang H; Wang J; Wang Y; Huang J; Yu J
    ACS Sens; 2019 Aug; 4(8):2140-2149. PubMed ID: 31353891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in targeted tracking and detection of soluble amyloid-β aggregates as a biomarker of Alzheimer's disease.
    Gao H; Chen J; Huang Y; Zhao R
    Talanta; 2024 Feb; 268(Pt 1):125311. PubMed ID: 37857110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease.
    Zhou Y; Liu L; Hao Y; Xu M
    Chem Asian J; 2016 Mar; 11(6):805-17. PubMed ID: 26994700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease.
    Zhang Y; Ding C; Li C; Wang X
    Adv Clin Chem; 2021; 103():135-190. PubMed ID: 34229849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis.
    Rezabakhsh A; Rahbarghazi R; Fathi F
    Biosens Bioelectron; 2020 Nov; 167():112511. PubMed ID: 32858422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review.
    Jeremic D; Jiménez-Díaz L; Navarro-López JD
    Ageing Res Rev; 2021 Dec; 72():101496. PubMed ID: 34687956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic Design of Amyloid-β Species Fluorescent Probes for Alzheimer's Disease.
    Su D; Diao W; Li J; Pan L; Zhang X; Wu X; Mao W
    ACS Chem Neurosci; 2022 Mar; 13(5):540-551. PubMed ID: 35132849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
    Du Z; Li M; Ren J; Qu X
    Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.
    Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM
    Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of three-dimensional semi-solid hydrogel matrices for ratiometric fluorescence sensing of Amyloid β peptide and imaging in SH-SY5 cells: Improvement of point of care diagnosis of Alzheimer's disease biomarker.
    Hamd-Ghadareh S; Salimi A; Parsa S; Mowla SJ
    Biosens Bioelectron; 2022 Mar; 199():113895. PubMed ID: 34968953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freestanding Nanofiber-Assembled Aptasensor for Precisely and Ultrafast Electrochemical Detection of Alzheimer's Disease Biomarkers.
    Liu H; Yuan X; Liu T; Zhang W; Dong H; Chu Z
    Adv Healthc Mater; 2024 Jun; 13(15):e2304355. PubMed ID: 38387159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers.
    Mobed A; Hasanzadeh M
    Int J Biol Macromol; 2020 Oct; 161():59-71. PubMed ID: 32504710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity.
    Rahimi F; Murakami K; Summers JL; Chen CH; Bitan G
    PLoS One; 2009 Nov; 4(11):e7694. PubMed ID: 19901993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.
    Rahimi F
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.